ABSTRACT
BACKGROUND: Burr hole covering in brain surgical procedures can avoid complications and unaesthetic results. The aim of this registry was to assess the safety and performance of a new polymeric burr hole covering device (Cranial COVER, NEOS Surgery). METHODS: A multicenter, prospective, clinical registry design was used for the study. All the patients who fulfilled the inclusion criteria were included in the study and followed up for 6 months. Baseline clinical parameters, surgical variables (technical success of the implantation, surgeon satisfaction), postoperative variables (aesthetic and functional results, neuroimaging artifacts), and adverse events were evaluated. RESULTS: Forty-three Cranial COVER devices were implanted in 30 patients. Most of them were implanted in frontal locations (53.5%). After implantation, 97.7% of the devices completely covered the burr hole, and 100% perfectly adapted to the skull surface. All surgeons ranked their satisfaction with the implantation procedure as very high or high. No artifacts were detected in any of the neuroimaging studies performed and no adverse events related with the device or its implantation were reported during the follow-up. There were significantly more scalp depressions associated with uncovered than with Cranial COVER-covered burr holes (p = 0.040). Patient satisfaction with covered burr holes located in the frontal and parietal areas was 9.0 ± 1.4 over 10. CONCLUSION: Cranial COVER is a safe and reliable burr hole covering system that offers excellent cosmetic results and high satisfaction rates for both surgeons and patients. Cranial COVER is highly adaptable to the skull surface, and it was predominantly used in frontal locations due to their cosmetic importance.
Subject(s)
Prostheses and Implants , Trephining , Humans , Prospective Studies , Trephining/methods , Skull/surgery , Craniotomy/methodsABSTRACT
INTRODUCCIÓN: El gliosarcoma es un tumor cerebral primario infrecuente similar al glioblastoma multiforme. En contrapartida al glioblastoma multiforme, debido a su componente sarcomatoso, los gliosarcomas tienen mayor tendencia a realizar metástasis extracraneales (11% de los casos). A pesar de ello, las metástasis medulares del gliosarcoma cerebral primario son extremadamente infrecuentes. CASO CLÍNICO: Se presenta el caso de una paciente intervenida de gliosarcoma cerebral que en el curso evolutivo de su enfermedad presenta una paraparesia, diagnosticándose e interviniéndose de metástasis medular de gliosarcoma. Realizamos una revisión sistemática de la literatura sobre los casos descritos de metástasis intramedular, sus características, el tratamiento realizado y el pronóstico. CONCLUSIONES: Únicamente se han descrito 4 casos de metástasis intramedular de gliosarcoma en la literatura. Se trata de una entidad infrecuente pero en la que debemos pensar ante la aparición de clínica medular en el curso evolutivo de un paciente con gliosarcoma cerebral
INTRODUCTION: Gliosarcoma is a rare neoplasm of the central nervous system, similar to glioblastoma multiforme. In contrast to glioblastoma, it is characterised by its propensity for extracranial metastasis (11% of the cases) due to its sarcomatous component. Intramedullary metastasis from primary gliosarcoma is extremely rare. CASE REPORT: A patient who had surgery for primary cerebral gliosarcoma developed paraparsis during the course of the disease. A magnetic resonance image showed an intramedullaryspinal cord metastasis requiring surgical treatment. This article reviews the literature on intramedullary spinal cord metastasis from gliosarcoma, and highlights the characteristics, treatment and overall survival. CONCLUSIONS: Only 4 cases of intramedullary gliosarcoma metastasis are described in the literature. This extremely rare entity should be suspected with the onset of spinal cord symptoms during the course of primary cerebral gliosarcoma
Subject(s)
Humans , Female , Middle Aged , Neoplasm Metastasis/pathology , Gliosarcoma/pathology , Spinal Cord Neoplasms/secondary , Neurosurgical Procedures/methods , Paraparesis/etiology , Disease-Free Survival , PrognosisABSTRACT
INTRODUCTION: Gliosarcoma is a rare neoplasm of the central nervous system, similar to glioblastoma multiforme. In contrast to glioblastoma, it is characterised by its propensity for extracranial metastasis (11% of the cases) due to its sarcomatous component. Intramedullary metastasis from primary gliosarcoma is extremely rare. CASE REPORT: A patient who had surgery for primary cerebral gliosarcoma developed paraparesis during the course of the disease. A magnetic resonance image showed an intramedullary spinal cord metastasis requiring surgical treatment. This article reviews the literature on intramedullary spinal cord metastasis from gliosarcoma, and highlights the characteristics, treatment and overall survival. CONCLUSIONS: Only 4 cases of intramedullary gliosarcoma metastasis are described in the literature. This extremely rare entity should be suspected with the onset of spinal cord symptoms during the course of primary cerebral gliosarcoma.
Subject(s)
Brain Neoplasms/pathology , Gliosarcoma/secondary , Spinal Cord Neoplasms/secondary , Fatal Outcome , Female , Humans , Middle AgedABSTRACT
No disponible
